• Home
  • Log In
  • Sign Up
  • Log Out
  • Create Post
Notifications
wait...

Novo Nordisk keeps Buy rating from Citi on Ozempic trials

03/06/2024 04:18
report
Novo Nordisk keeps Buy rating from Citi on Ozempic trials

Citi analysts maintained a Buy rating on Novo Nordisk (NVO) stock over the results of an Ozempic trial showing that the GLP-1 weight loss drug delayed the progression of chronic kidney disease in patients, cutting the risk of a cardiac event by 24%. Yahoo Finance Anchors Josh Lipton and Julie Hyman break down the latest development for Novo Nordisk and its rating from Citi, and how it may affect the company moving forward. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Nicholas Jacobino

  • Barrons.com

    Coinbase Stock Is Riding Bitcoin’s Wave. A Major Court Decision Looms.

    Coinbase Global stock is skyrocketing on the back of Bitcoin seeming inexorable rise. Nine months after the Securities and Exchange Commission filed a case against Coinbase for allegedly operating an unregistered securities exchange, the judge in the case will likely soon rule on whether the agency has purview over much of the crypto market in the first place. If U.S. District Judge Katherine Polk Failla says the SEC doesn’t have purview, Coinbase and other crypto projects would likely see an immediate boost.

  • The Wall Street Journal

    Five Signs That Market Breadth Is Picking Up

    Shares of the Magnificent Seven are making room for other stocks on their way up, which some investors say is a sign of a [healthier stock market less-dependent](https://www.wsj.com/finance/rise-in-stocks-bonds-crypto-gold-683f0e91) on the performance of a few big companies.

  • CoinDesk

    Bitcoin Hit a Record High. Here's What Might Happen Next

    Bitcoin hit a record $69,325, its highest level since November 2021 on a flurry of volatility buoyed by demand from spot BTC exchange-traded funds (ETFs). Unlike previous cycles, it almost instantly fell back as bearish traders wrangled for control.

  • Benzinga

    Mark Cuban Attacks Trump, Endorses Biden in Fiery Statement

    Mark Cuban’s acknowledgment of Tesla Inc. (NASDAQ:TSLA) interest in his Cost Plus Drugs initiative, which focuses on reducing healthcare costs, has significant implications for investors, particularly those watching Real Estate Investment Trusts (REITs) like Welltower Inc. (NYSE:WELL) and Digital Realty Trust (NYSE:DLR). This development is part of a larger conversation that’s been brewing, fueled by the ongoing, very public dialogue between Cuban and Elon Musk. Their exchanges have been marked

Read more --->


0 Like 0 Share Tweet -42203 2 0 finance.yahoo.com markets
wait...

Related news

Disaster Recovery as a Service in the US for Cloud-Driven Businesses Ensuring Operational Resilience

www.ibntech.com 27 days ago


Crypto Advisory Council Coming to New York City

coindesk.com 247 days ago


Bitcoin (BTC) News: 'Buy in May and Go Away' as Crypto Bucks Summer Lull, Analysts Say

coindesk.com 247 days ago


Bitcoin dominance hits key resistance zone: is alt-season around the corner?

crypto.news 247 days ago


Beer 2.0: the meme coin that’s brewing something bigger on Solana

cryptobriefing.com 247 days ago


HBAR price analysis as Hedera flips Stellar, Algorand on key metric

crypto.news 247 days ago


NYC’s 'Bitcoin Mayor' Eric Adams Reveals Plans to Boost 'Demonized' Crypto Industry - Decrypt

decrypt.co 247 days ago


Genesis Files Suits Against DCG to Recover Billions Worth of Allegedly Fraudulent Transfers

coindesk.com 247 days ago


Telegram CEO Says French Intelligence Asked Him to Ban Romanian Election Channels - Decrypt

decrypt.co 247 days ago


Energy Company’s Latest Bitcoin Buy Brings Treasury to $78 Million - Decrypt

decrypt.co 247 days ago


Login
Sign Up
Show password
Forgot password?
Wait...
Show password

Read terms of use và Privacy
wait...
© 2023 - CoinWebKo.com Whitepaper - Terms of use - Privacy - Email: [email protected] - Twitter